Artificial Intelligence is increasingly embedded across pharmaceutical processes — from clinical analytics and pharmacovigilance to manufacturing optimization. However, AI adoption in regulated environments requires more than technical implementation; it demands structured governance.

In this episode of The GMP Insider, we examine how Quality leaders can prepare for AI integration within GxP systems.

Discussion topics include:
• Defining intended use and GxP impact
• Evolving validation approaches for dynamic models
• Protecting data integrity and audit trail transparency
• Establishing oversight and accountability structures
• Cross-functional collaboration in AI deployment

AI introduces efficiency and automation, but it also shifts responsibility. Quality professionals must ensure that intelligent systems operate within validated, controlled, and transparent frameworks.

The future of pharmaceutical innovation will depend not only on AI capability, but on strong governance led by Quality.